Marcello Gaudiano
Cornell University(US)Presbyterian Hospital(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Lung Cancer Treatments and Mutations, Viral-associated cancers and disorders
Most-Cited Works
- → Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma(2015)435 cited
- → Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors(2017)220 cited
- → Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial(2014)182 cited
- → THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors(2017)107 cited
- → Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas(2015)99 cited
- → The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank(2016)47 cited
- → A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation(2014)47 cited
- → Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis(2017)20 cited
- → Abstract 5690: Discovery of JNJ-67856633: A novel, first-in-class MALT1 protease inhibitor for the treatment of B cell lymphomas(2020)14 cited
- → Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma(2018)12 cited